Physician

Jose M Casanova, MD PHD

According to 2025 Medicare claims, Jose Casanova, MD PHD (NPI: 1851325542) practices neurology in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is SUMMA PHYSICIANS LLC (NPI: 1275718850; TIN: 341790929) and primary practice location at 44319-2299. Casanova is affiliated with the Summa Accountable Care Organization (ACO ID: A1063), participating under the MSSP model.

Casanova's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 251 traditional Medicare patients, billed 35,553 HCPCS/CPT codes, and received $194,988 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,689 prescription claims across 411 beneficiaries totaling $734,596 in drug costs, led by Nurtec Odt (Rimegepant Sulfate). DME data shows 12 claims. Open Payments data shows 10 records totaling $275. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $289,256 to $194,988. Similarly, Part D prescription costs have declined steadily, from $1,492,659 to $734,596. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,189 to $883.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	485	37,702	$289,256
2016	566	36,774	$293,335
2017	536	34,822	$269,061
2018	525	25,439	$240,907
2019	464	27,779	$255,570
2020	211	23,973	$152,702
2021	234	37,221	$209,915
2022	248	36,812	$194,720
2023	240	41,211	$211,682
2024	251	35,553	$194,988

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	561	6,790	$1,492,659
2016	541	6,408	$1,543,236
2017	531	6,760	$1,355,036
2018	499	6,962	$1,350,241
2019	494	7,805	$1,482,051
2020	441	4,907	$869,609
2021	342	3,206	$940,817
2022	397	3,094	$1,024,439
2023	390	2,719	$707,573
2024	411	2,689	$734,596

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	20	$376
2017	N/R	12	$96
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$883

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	40	40	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	81	118	$76
62369	Electronic analysis reprogramming and refill of spinal canal drug infusion pump	28	62	$58
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	96	129	$57
J0585	Injection, onabotulinumtoxina, 1 unit	45	30,900	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nurtec Odt	Rimegepant Sulfate	82	2,356	$83,451
Ajovy Autoinjector	Fremanezumab-Vfrm	51	2,430	$53,173
Kevzara	Sarilumab	12	336	$48,990
Emgality Pen	Galcanezumab-Gnlm	33	1,406	$31,774
Ubrelvy	Ubrogepant	27	910	$30,795

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$883

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$275	Alexion Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jose M. Casanova, MD PHD?

Tedicare shows public-source Medicare data for Jose M. Casanova, MD PHD (NPI 1851325542), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jose M. Casanova, MD PHD have ACO affiliation data?

Jose M. Casanova, MD PHD is shown with ACO affiliation data for Summa Accountable Care Organization (MSSP, ACO ID A1063).

What billing organization is linked to Jose M. Casanova, MD PHD?

Jose M. Casanova, MD PHD is linked to SUMMA PHYSICIANS LLC (billing NPI 1275718850) in the available physician profile data.

Does Jose M. Casanova, MD PHD have Open Payments data?

Jose M. Casanova, MD PHD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.